1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Analysis of the Western European Biomarkers Market in Drug Discovery and Development

Increasing Applications of Biomarkers are Driving Growth

Biomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends and dynamics are analysed in this study. This research service offers market overview, Market Engineering measurements, revenue forecasts, company profiling and key trends for the market and its segments, namely, genomics, proteomics, metabolomics and imaging biomarkers.

Methodology

-The information contained in this research service was derived from a variety of relevant primary and secondary information sources.
-Primary interviews were conducted with leading tier 1 and tier 2 companies and industry stakeholders, such as key clinicians, the research and development (R&D) community, heads of business development, laboratory personnel and key opinion leaders.
-Secondary data sources include government and public health organisation Websites, the World Health Organization (WHO), the European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA) publications, annual reports, investor presentations, press releases, government public sources, pharmaceutical industry databases and published articles in scientific and medical journals.
-For the total biomarkers and segments, revenue forecasting is performed using a robust, data-driven approach. Current trends, products, technologies and emerging trends have been taken into account, and aggregate figures are provided.
For Market Engineering research, Frost & Sullivan uses tried and tested marketing techniques to provide structure to the research and an easy format to compare results across different countries and markets over time. This project was carried out using primary (telephone or face-to-face interviews) and secondary (published and online material) research as the principle methods of data gathering. The focus of the interviews for this project was primarily the respondent types outlined below.
-Industry participants
-End users
-Key regulatory bodies
-Frost & Sullivan published research services
-Decision support databases
-Country industry forecasts
-Proprietary databases

Key Findings

-The Western European biomarkers market in drug discovery and development will continue to grow - from $ million in 2013 to $ million in 2019, at a compound annual growth rate (CAGR) of % from 2013 to 2020.The use of biomarker-based tests in drug discovery, early diagnosis and prognosis is in the growth stage.
-Advancements in multiplexing will lead to the development of biomarker panels with a higher clinical value. The discovery of biomarkers from samples like urine, breath and saliva, as well as the development of noninvasive tests, will find increased application in infectious disease and cancer testing, in which repeat studies are needed to be able monitor the diseases.
-The development of multi-biomarker panels that can be used to provide accurate predictive value is important, and companies are working towards discovering and integrating results from different discovery platforms to build such panels.
-The adoption of genomics- and proteomics-based biomarkers is currently the highest, with a number of novel lipidomics and immunomics markers also coming to the fore.
-Complex diseases with unmet needs are the major potential areas for biomarker development. Traumatic brain injury (TBI), cardiovascular diseases and autoimmune diseases are some of the areas witnessing quality R&D of novel biomarker-based tests.
-Various European Governments and health authorities are focussing on investing their funding in biomarker R&D. Various knowledge networks and consortia have been formed to help this cause. The U.K. Biobank, the Biomarkers Consortium and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) E-Register of Studies are some examples.

Table Of Contents

Analysis of the Western European Biomarkers Market in Drug Discovery and Development
1. EXECUTIVE SUMMARY

Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO's Perspective
Key Companies to Watch
Market Attractiveness by Region
3 Big Predictions

2. MARKET OVERVIEW

Market Background
Market Overview
Market Segmentation
Defining Future Healthcare Trends

3. COMPETITIVE PLAYBOOK

New Market Opportunities
Merger, Acquisition and Partnership Assessment

4. DRIVERS, RESTRAINTS AND TRENDS—TOTAL BIOMARKERS MARKET IN DRUG DISCOVERY AND DEVELOPMENT

Market Drivers
Market Restraints
Impact Mapping of Drivers and Restraints

5. FORECAST AND TRENDS—TOTAL BIOMARKERS MARKET IN DRUG DISCOVERY AND DEVELOPMENT

Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast Discussion
Per cent Revenue Forecast by Segment
Revenue Forecast by Segment
Biomarkers Market Outlook in Europe
Per cent Revenue by Region

6. EMERGING TRENDS

Technology Trends
Market Trends
Emerging Trends
Technology Lifecycle Analysis

7. GENOMICS SEGMENT BREAKDOWN

Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Genomics Segment—Metrics Analysis
Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics

8. PROTEOMICS SEGMENT BREAKDOWN

Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Proteomics Segment—Metrics Analysis
Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics

9. METABOLOMICS SEGMENT BREAKDOWN

Market Engineering Measurements
Revenue Forecast
Revenue Forecast discussion
Metabolomics Segment—Metrics Analysis
Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics

10. IMAGING SEGMENT BREAKDOWN

Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Imaging Segment—Metrics Analysis
Growth Opportunity Analysis for Imaging in Drug Discovery and Companion Diagnostics

11. BIOMARKER RESEARCH CLUSTERS

UK Biobank
The Biomarkers Consortium
Other Biomarker Research Projects

12. REGIONAL ANALYSIS

Market Attractiveness by Region
Regional Analysis—The United Kingdom
Regional Analysis—Germany
Regional Analysis—France
Regional Analysis—Italy
Regional Analysis—Spain
Regional Analysis—Benelux
Regional Analysis—Scandinavia

13. KEY COMPANIES TO WATCH

Aepodia S.A.
Affymetrix
Almac Group
Argutus Medical Limited (EKF Diagnostics Group)
AROS Applied Biotechnology A/S
Bio-Rad Laboratories, Inc.
BioSystems International
Biovica International AB
Diagenic ASA
DNAVision SA
Epigenomics AG
Epistem Plc
Eurofins Scientific
Indivumed GmbH
Metabometrix
Pronota NV
Protagen AG
Proteome Sciences
ProteoSys AG
QIAGEN
Roche
Thermo Fisher Scientific

14. THE LAST WORD

The Last Word—3 Big Predictions
The Last Word—Discussion
Legal Disclaimer

15. APPENDIX

Drivers Explained
Restraints Explained
List of Other Companies in Biomarkers Research, Development and/or Services
Decision Support Database
Additional Sources of Information on Diabetes
Market Engineering Methodology
Learn More—Next Steps

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth ...

Cancer Biomarkers - Global Market Outlook (2016-2022)

Cancer Biomarkers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in the US

  • November 2016
    10 pages
  • Genetic  

    Cardiovascular ...  

  • United States  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Biomarker

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.